Restriction of lentivirus in monkeys.

PubWeight™: 5.02‹?› | Rank: Top 1%

🔗 View Article (PMC 129369)

Published in Proc Natl Acad Sci U S A on August 01, 2002

Authors

Caroline Besnier1, Yasuhiro Takeuchi, Greg Towers

Author Affiliations

1: Wohl Virion Centre, Department of Immunology and Molecular Pathology, University College London, 46 Cleveland Street, London W1T 4JF, United Kingdom.

Articles citing this

(truncated to the top 100)

Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor. Proc Natl Acad Sci U S A (2006) 6.82

Trim5alpha protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A (2004) 5.31

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha. Proc Natl Acad Sci U S A (2004) 5.15

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A (2004) 5.08

Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction. J Virol (2005) 4.64

TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells. Proc Natl Acad Sci U S A (2004) 4.60

Restriction of multiple divergent retroviruses by Lv1 and Ref1. EMBO J (2003) 4.19

A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1. Proc Natl Acad Sci U S A (2004) 4.06

The B30.2(SPRY) domain of the retroviral restriction factor TRIM5alpha exhibits lineage-specific length and sequence variation in primates. J Virol (2005) 3.63

Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nat Immunol (2010) 3.45

Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A (2006) 3.43

Retrovirus restriction by TRIM5alpha variants from Old World and New World primates. J Virol (2005) 3.03

Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc Natl Acad Sci U S A (2004) 3.03

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog (2009) 2.92

Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells. J Virol (2003) 2.73

Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells. Proc Natl Acad Sci U S A (2003) 2.71

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I. J Virol (2006) 2.65

The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology (2007) 2.54

Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells. J Virol (2005) 2.54

Retroviral restriction factor TRIM5alpha is a trimer. J Virol (2005) 2.52

Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity. J Virol (2004) 2.51

Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity. J Virol (2005) 2.47

Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities. Nucleic Acids Res (2005) 2.43

Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles. J Virol (2005) 2.43

Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid. J Virol (2004) 2.41

Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid. J Virol (2004) 2.37

Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol (2006) 2.32

Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection. J Virol (2006) 2.31

All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction. J Virol (2006) 2.26

Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc Natl Acad Sci U S A (2008) 2.23

Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells. Proc Natl Acad Sci U S A (2005) 2.21

The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid. J Virol (2006) 2.17

Independent evolution of an antiviral TRIMCyp in rhesus macaques. Proc Natl Acad Sci U S A (2008) 2.15

HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature (2013) 2.06

Characterization of murine leukemia virus restriction in mammals. J Virol (2003) 1.97

Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog (2008) 1.96

Early steps of retrovirus replicative cycle. Retrovirology (2004) 1.94

Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res (2009) 1.94

As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity. J Virol (2003) 1.94

A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses (2007) 1.92

A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection. J Virol (2005) 1.85

An intracellular block to primate lentivirus replication. Proc Natl Acad Sci U S A (2002) 1.81

Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells. J Virol (2005) 1.79

Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells. J Virol (2006) 1.77

Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77

Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins. J Virol (2005) 1.71

Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G. J Virol (2006) 1.69

Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells. J Virol (2010) 1.69

Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity. J Virol (2006) 1.69

Multiploid inheritance of HIV-1 during cell-to-cell infection. J Virol (2011) 1.66

Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle. J Virol (2006) 1.66

CPSF6 defines a conserved capsid interface that modulates HIV-1 replication. PLoS Pathog (2012) 1.64

Genetic association of the antiviral restriction factor TRIM5alpha with human immunodeficiency virus type 1 infection. J Virol (2006) 1.62

CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry. J Virol (2008) 1.62

HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. Virology (2007) 1.61

Influence of gag on human immunodeficiency virus type 1 species-specific tropism. J Virol (2004) 1.57

Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells. J Virol (2004) 1.57

Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA. J Virol (2004) 1.56

An active TRIM5 protein in rabbits indicates a common antiviral ancestor for mammalian TRIM5 proteins. J Virol (2007) 1.54

Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat Struct Mol Biol (2009) 1.53

Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc Natl Acad Sci U S A (2006) 1.53

Novel approaches to inhibiting HIV-1 replication. Antiviral Res (2009) 1.48

Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent. Antimicrob Agents Chemother (2008) 1.46

Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains. J Virol (2006) 1.38

Gag determinants of fitness and drug susceptibility in protease inhibitor-resistant human immunodeficiency virus type 1. J Virol (2009) 1.37

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis (2005) 1.36

X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J Virol (2007) 1.36

Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals. J Virol (2006) 1.35

Retroviral capsid determinants of Fv1 NB and NR tropism. J Virol (2004) 1.35

HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation. AIDS (2009) 1.34

Murine T cells potently restrict human immunodeficiency virus infection. J Virol (2004) 1.32

Rhesus macaque TRIM5 alleles have divergent antiretroviral specificities. J Virol (2008) 1.29

Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alpha. J Virol (2008) 1.28

Structural analyses of purified human immunodeficiency virus type 1 intracellular reverse transcription complexes. J Virol (2003) 1.27

Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription. J Virol (2006) 1.25

Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain. J Virol (2005) 1.24

Inhibition of reverse transcriptase activity increases stability of the HIV-1 core. J Virol (2012) 1.21

Effects of valproic acid derivatives on inositol trisphosphate depletion, teratogenicity, glycogen synthase kinase-3beta inhibition, and viral replication: a screening approach for new bipolar disorder drugs derived from the valproic acid core structure. Mol Pharmacol (2005) 1.20

HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology (2009) 1.20

HIV-1 capsid-targeting domain of cleavage and polyadenylation specificity factor 6. J Virol (2012) 1.19

Interaction of Moloney murine leukemia virus matrix protein with IQGAP. EMBO J (2006) 1.19

Restriction of foamy viruses by primate Trim5alpha. J Virol (2008) 1.19

Lv2, a novel postentry restriction, is mediated by both capsid and envelope. J Virol (2004) 1.16

TRIM5alpha disrupts the structure of assembled HIV-1 capsid complexes in vitro. J Virol (2010) 1.15

Heterologous human immunodeficiency virus type 1 lentiviral vectors packaging a simian immunodeficiency virus-derived genome display a specific postentry transduction defect in dendritic cells. J Virol (2003) 1.15

Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant. J Virol (2007) 1.13

Fates of retroviral core components during unrestricted and TRIM5-restricted infection. PLoS Pathog (2013) 1.13

Control of viral infectivity by tripartite motif proteins. Hum Gene Ther (2005) 1.10

Residues in the murine leukemia virus capsid that differentially govern resistance to mouse Fv1 and human Ref1 restrictions. J Virol (2005) 1.09

Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity. PLoS Pathog (2010) 1.09

Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells. J Virol (2006) 1.09

TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation. J Virol (2013) 1.08

ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity. J Virol (2005) 1.08

Designing and Interpreting Limiting Dilution Assays: General Principles and Applications to the Latent Reservoir for Human Immunodeficiency Virus-1. Open Forum Infect Dis (2015) 1.08

HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci U S A (2005) 1.07

Host restriction factors in retroviral infection: promises in virus-host interaction. Retrovirology (2012) 1.05

Overexpression of fasciculation and elongation protein zeta-1 (FEZ1) induces a post-entry block to retroviruses in cultured cells. Genes Dev (2005) 1.05

In defense of the cell: TRIM5alpha interception of mammalian retroviruses. Proc Natl Acad Sci U S A (2004) 1.03

Arsenic counteracts human immunodeficiency virus type 1 restriction by various TRIM5 orthologues in a cell type-dependent manner. J Virol (2006) 1.01

Multiple restrictions of human immunodeficiency virus type 1 in feline cells. J Virol (2007) 1.00

Articles cited by this

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 28.95

Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97

Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology (1975) 10.56

Positional cloning of the mouse retrovirus restriction gene Fv1. Nature (1996) 7.01

A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J Exp Med (1971) 5.50

A conserved mechanism of retrovirus restriction in mammals. Proc Natl Acad Sci U S A (2000) 4.88

Species-specific, postentry barriers to primate immunodeficiency virus infection. J Virol (1999) 4.54

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection. J Virol (1997) 4.19

Use of a transient assay for studying the genetic determinants of Fv1 restriction. J Virol (2000) 3.53

Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells. J Virol (1991) 3.05

Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther (2000) 2.95

Restriction of HIV-1 (subtype B) replication at the entry step in rhesus macaque cells. Virology (1996) 2.83

Early replication block of human immunodeficiency virus type 1 in monkey cells. J Gen Virol (1995) 2.73

Replication kinetics of N- and B-tropic murine leukemia viruses on permissive and nonpermissive cells in vitro. Virology (1975) 2.62

Abrogation of Ref1 retrovirus restriction in human cells. J Virol (2002) 2.60

Mutation of amino acids within the gibbon ape leukemia virus (GALV) receptor differentially affects feline leukemia virus subgroup B, simian sarcoma-associated virus, and GALV infections. J Virol (1993) 2.43

The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J Virol (1996) 2.43

Cloning of a new murine endogenous retrovirus, MuERV-L, with strong similarity to the human HERV-L element and with a gag coding sequence closely related to the Fv1 restriction gene. J Virol (1997) 2.35

Interclass transmission and phyletic host tracking in murine leukemia virus-related retroviruses. J Virol (1999) 2.15

Dual susceptibility of A 3T3 mouse cell line to infection by N- and B-tropic murine leukemia virus: apparent lack of expression of the FV-1 gene. Int J Cancer (1974) 1.65

Characterization of Fv-1 host range strains of murine retroviruses by titration and p30 protein characteristics. Virology (1979) 1.55

Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Ther (2002) 1.53

One step screening of retroviral producer clones by real time quantitative PCR. J Gene Med (2000) 1.50

Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase. Biochemistry (1996) 1.40

From Pan to pandemic. Nature (1999) 1.07

Fv-1 N- and B-tropism-specific sequences in murine leukemia virus and related endogenous proviral genomes. J Virol (1988) 1.07

Articles by these authors

(truncated to the top 100)

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest (2004) 7.00

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res (2003) 6.81

Analyses of pig genomes provide insight into porcine demography and evolution. Nature (2012) 5.58

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab (2002) 4.17

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology (2002) 3.00

Abrogation of Ref1 retrovirus restriction in human cells. J Virol (2002) 2.60

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun (2004) 2.52

Simian immunodeficiency virus envelope glycoprotein counteracts tetherin/BST-2/CD317 by intracellular sequestration. Proc Natl Acad Sci U S A (2009) 2.21

Retracted Cytokines suppress adipogenesis and PPAR-gamma function through the TAK1/TAB1/NIK cascade. Nat Cell Biol (2003) 2.08

Dose-dependent neurologic abnormalities in workers exposed to 1-bromopropane. J Occup Environ Med (2010) 1.99

Characterization of murine leukemia virus restriction in mammals. J Virol (2003) 1.97

Use of CD134 as a primary receptor by the feline immunodeficiency virus. Science (2004) 1.93

A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses (2007) 1.92

Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet (2002) 1.89

A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A (2009) 1.80

Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. Virology (2003) 1.77

Xenotransplantation-associated infectious risk: a WHO consultation. Xenotransplantation (2012) 1.65

Continuous high-titer HIV-1 vector production. Nat Biotechnol (2003) 1.58

A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab (2005) 1.56

Surgical management and outcomes in patients with Cushing disease with negative pituitary magnetic resonance imaging. World Neurosurg (2011) 1.55

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem (2006) 1.46

Ghrelin directly regulates bone formation. J Bone Miner Res (2004) 1.44

Impaired glucose metabolism in Japanese patients with acromegaly is restored after successful pituitary surgery if pancreatic {beta}-cell function is preserved. Eur J Endocrinol (2011) 1.40

Comparison of two assays for fibroblast growth factor (FGF)-23. J Bone Miner Metab (2005) 1.36

Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes. Emerg Infect Dis (2005) 1.36

Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol (2008) 1.35

Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res (2007) 1.33

Central control of bone remodeling by neuromedin U. Nat Med (2007) 1.32

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab (2007) 1.31

Runx1 and Runx2 cooperate during sternal morphogenesis. Development (2010) 1.24

Identification of receptors for pig endogenous retrovirus. Proc Natl Acad Sci U S A (2003) 1.23

PCR-based cloning and immunocytological titration of infectious porcine endogenous retrovirus subgroup A and B. J Gen Virol (2002) 1.14

Tubulovesicular structures within vesicular stomatitis virus G protein-pseudotyped lentiviral vector preparations carry DNA and stimulate antiviral responses via Toll-like receptor 9. J Virol (2006) 1.13

Evidence and consequence of porcine endogenous retrovirus recombination. J Virol (2004) 1.10

Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. J Virol (2005) 1.09

Receptor tyrosine kinases inhibit bone morphogenetic protein-Smad responsive promoter activity and differentiation of murine MC3T3-E1 osteoblast-like cells. J Bone Miner Res (2003) 1.09

Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association. J Virol (2003) 1.05

Decrease in serum leptin by troglitazone is associated with preventing bone loss in type 2 diabetic patients. J Bone Miner Metab (2003) 1.05

A large functioning parathyroid cyst in a patient with multiple endocrine neoplasia type 1. Endocr J (2013) 1.05

Recurrence of primary hyperparathyroidism following spontaneous remission with intracapsular hemorrhage of a parathyroid adenoma. J Bone Miner Metab (2008) 1.05

Stimulation of Smad1 transcriptional activity by Ras-extracellular signal-regulated kinase pathway: a possible mechanism for collagen-dependent osteoblastic differentiation. J Bone Miner Res (2002) 1.04

Determinants of high titer in recombinant porcine endogenous retroviruses. J Virol (2004) 1.04

1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis. J Clin Endocrinol Metab (2005) 1.02

Avian-human influenza epidemic model. Math Biosci (2006) 1.00

Innate immune interferon responses to human immunodeficiency virus-1 infection. Rev Med Virol (2012) 0.99

SVIR epidemic models with vaccination strategies. J Theor Biol (2007) 0.99

Complementary cooperation between two syntrophic bacteria in pesticide degradation. J Theor Biol (2008) 0.99

Regulation of porcine endogenous retrovirus release by porcine and human tetherins. J Virol (2009) 0.98

Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. J Virol (2002) 0.97

Trichloroethylene causes generalized hypersensitivity skin disorders complicated by hepatitis. J Occup Health (2008) 0.96

Long-term IgG response to porcine Neu5Gc antigens without transmission of PERV in burn patients treated with porcine skin xenografts. J Immunol (2013) 0.96

Xenotransplantation and pig endogenous retroviruses. Rev Med Virol (2003) 0.96

Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat. J Virol (2010) 0.95

Optimal control strategy for prevention of avian influenza pandemic. J Theor Biol (2009) 0.95

High incidence of low O(6)-methylguanine DNA methyltransferase expression in invasive macroadenomas of Cushing's disease. Eur J Endocrinol (2009) 0.95

The distinct role of the Runx proteins in chondrocyte differentiation and intervertebral disc degeneration: findings in murine models and in human disease. Arthritis Rheum (2008) 0.95

A comparison of indoor air pollutants in Japan and Sweden: formaldehyde, nitrogen dioxide, and chlorinated volatile organic compounds. Environ Res (2004) 0.94

The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activity. Mol Ther (2012) 0.93

Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Hum Gene Ther (2010) 0.93

Neurologic abnormalities in workers of a 1-bromopropane factory. Environ Health Perspect (2004) 0.92

Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques. PLoS One (2011) 0.92

Global analysis on delay epidemiological dynamic models with nonlinear incidence. J Math Biol (2010) 0.92

Prevention of avian influenza epidemic: what policy should we choose? J Theor Biol (2008) 0.92

Human herpesvirus 6 reactivation in trichloroethylene-exposed workers suffering from generalized skin disorders accompanied by hepatic dysfunction. J Occup Health (2006) 0.90

Permanence of single-species stage-structured models. J Math Biol (2003) 0.90

A survey of semen indices in insecticide sprayers. J Occup Health (2004) 0.89

Porcine endogenous retrovirus and other viruses in xenotransplantation. Curr Opin Organ Transplant (2009) 0.89

Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Mol Ther (2005) 0.89

Hypoglycemic coma in a patient with anorexia nervosa coincident with acute exacerbation of liver injury induced by oral intake of nutrients. Intern Med (2010) 0.87

Exposure to 1-bromopropane causes ovarian dysfunction in rats. Toxicol Sci (2003) 0.87

Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy. Bone (2007) 0.87

A survey on exposure level, health status, and biomarkers in workers exposed to 1-bromopropane. Am J Ind Med (2004) 0.87

Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis. Curr Gene Ther (2013) 0.87

Dynamical properties of autoimmune disease models: tolerance, flare-up, dormancy. J Theor Biol (2007) 0.87

Safer, silencing-resistant lentiviral vectors: optimization of the ubiquitous chromatin-opening element through elimination of aberrant splicing. J Virol (2012) 0.86

Adaptation of prey and predators between patches. J Theor Biol (2009) 0.86

Avian flu pandemic: Can we prevent it? J Theor Biol (2008) 0.86

Hollow fiber vitrification provides a novel method for cryopreserving in vitro maturation/fertilization-derived porcine embryos. Biol Reprod (2012) 0.85

Dose-dependent biochemical changes in rat central nervous system after 12-week exposure to 1-bromopropane. Neurotoxicology (2003) 0.85

A geographical spread of vaccine-resistance in avian influenza epidemics. J Theor Biol (2009) 0.84

Spreading disease with transport-related infection. J Theor Biol (2005) 0.84

Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg (2014) 0.83

Differential resistance to cell entry by porcine endogenous retrovirus subgroup A in rodent species. Retrovirology (2007) 0.83

Reduced sensitivity to human serum inactivation of enveloped viruses produced by pig cells transgenic for human CD55 or deficient for the galactosyl-alpha(1-3) galactosyl epitope. J Virol (2004) 0.83

Coincidence of multiple endocrine neoplasia type 2A with acromegaly. Am J Med Sci (2010) 0.83

A family of autosomal dominant hypocalcemia with an activating mutation of calcium-sensing receptor gene. Endocr J (2003) 0.83

Microbial safety in xenotransplantation. Curr Opin Organ Transplant (2011) 0.83

Transsphenoidal cyst cisternostomy with a keyhole dural opening for sellar arachnoid cysts: technical note. Neurosurg Rev (2013) 0.82

Scalp hair loss after transsphenoidal adenomectomy in patients with acromegaly. Clin Endocrinol (Oxf) (2013) 0.82

Immune impairment in HIV infection: existence of risky and immunodeficiency thresholds. J Theor Biol (2009) 0.82

Production of diabetic offspring using cryopreserved epididymal sperm by in vitro fertilization and intrafallopian insemination techniques in transgenic pigs. J Reprod Dev (2013) 0.81

Short-term preoperative octreotide treatment for TSH-secreting pituitary adenoma. Endocr J (2014) 0.81

Biochemical changes in the central nervous system of rats exposed to 1-bromopropane for seven days. Toxicol Sci (2002) 0.81

Strategies to enhance the safety profile of xenotransplantation: minimizing the risk of viral zoonoses. Curr Opin Organ Transplant (2008) 0.81

Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5alpha proteins including human TRIM5alpha. J Gen Virol (2009) 0.81

Biodegradable β-tricalcium phosphate cement with anti-washout property based on chelate-setting mechanism of inositol phosphate. J Mater Sci Mater Med (2013) 0.80

Acetyl tributyl citrate, the most widely used phthalate substitute plasticizer, induces cytochrome p450 3a through steroid and xenobiotic receptor. Toxicol Sci (2011) 0.80

Fibroblast growth factor (FGF)23 in patients with acromegaly. Endocr J (2007) 0.80

Global stability for delay SIR and SEIR epidemic models with nonlinear incidence rate. Bull Math Biol (2010) 0.79

Immune impairment thresholds in HIV infection. Immunol Lett (2009) 0.79